Inflammasome activation in neutrophils of patients with severe COVID-19
Karen Aymonnier(Inserm), Denisa D. Wagner(Boston Children's Hospital), Patrick Münzer(Boston Children's Hospital), Julie Ng(Brigham and Women's Hospital), Michaël Desjardins(Centre Hospitalier de l’Université de Montréal), James A. Lederer(Brigham and Women's Hospital), Meera Subramaniam(Pulmonary Associates), Katherin Zambrano-Vera(Brigham and Women's Hospital), Benjamin A. Raby(Brigham and Women's Hospital), Mark A. Perrella(Brigham and Women's Hospital), Sarah Gutch(Boston Children's Hospital), Rebecca M. Baron(Brigham and Women's Hospital), Laura E. Fredenburgh(Brigham and Women's Hospital), Shoichi Fukui(Boston Children's Hospital)
Cited by 92
Related Papers
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981
The immune cell landscape in kidneys of patients with lupus nephritis
|Nature Immunology|2019|840
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.
|Proceedings of the National Academy of Sciences|1994|806
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life.
|Circulation Research|1993|776